APO Research
Talk to an analyst

APO RESEARCH · REPORT

Pemetrexed Disodium for Injection

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Pemetrexed Disodium for Injection Market Outlook and Growth Opportunities 2026

22 December 2025219 pages

Choose your research edition.

Industry ResearchPemetrexed Disodium for Injection Industry Research Report 2026146 pages · $2,950 USDIndustry Growth & TrendsGlobal Pemetrexed Disodium for Injection Industry Growth and Trends Forecast to 2032127 pages · $3,450 USDMarket StructureGlobal Pemetrexed Disodium for Injection Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032199 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Pemetrexed Disodium for Injection Market Outlook and Growth Opportunities 2026219 pages · $4,250 USDMarket Analysis & ForecastGlobal Pemetrexed Disodium for Injection Market Analysis and Forecast 2026-2032213 pages · $4,950 USD

Market perspective

The global Pemetrexed Disodium for Injection market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Pemetrexed Disodium for Injection is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Pemetrexed Disodium for Injection is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Pemetrexed Disodium for Injection is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Pemetrexed Disodium for Injection market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Pemetrexed Disodium for Injection market include Accord Healthcare, Amneal Pharmaceuticals, APOTEX, Biocon, Dr. Reddy's Laboratories, Eugia Pharma, Nang Kuang Pharmaceutical, Pfizer (Hospira) and Waverley Pharma, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Pemetrexed Disodium for Injection market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Pemetrexed Disodium for Injection and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Pemetrexed Disodium for Injection sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Pemetrexed Disodium for Injection market size, projected growth trends, production technologies, key applications, and end-use industries.

Pemetrexed Disodium for Injection Segment by Company

Accord Healthcare

Amneal Pharmaceuticals

APOTEX

Biocon

Dr. Reddy's Laboratories

Eugia Pharma

Nang Kuang Pharmaceutical

Pfizer (Hospira)

Waverley Pharma

Zydus Lifesciences

Baxter

Beijing Xiehe Pharmaceutical

Dezhou Deyao Pharmaceutical

Fresenius Kabi

Hainan Jinrui Pharmaceutical

Kelun Pharmaceutical

Jiangsu Aosaikang Pharmaceutical

Qilu Pharmaceutical

Lilly

Lianyungang Jaripharm Pharmaceutical

Nanjing Pharmaceutical Factory

Jiangsu Hansoh Pharmaceutical

Sandoz

Zhendong Group

Shanghai Chemo Wanbang Biopharma

Sichuan Huiyu Pharmaceutical

Suzhou Erye Pharmaceutical

Suzhou Thery Pharmaceutical

Jiangsu Simcere Pharmaceutical

Yangtze River Pharmaceutical Group

Pemetrexed Disodium for Injection Segment by Type

500mg/Pcs

100mg/Pcs

Pemetrexed Disodium for Injection Segment by Application

Hospitals

Clinics

Others

Pemetrexed Disodium for Injection Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Pemetrexed Disodium for Injection status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Pemetrexed Disodium for Injection market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Pemetrexed Disodium for Injection significant trends, drivers, influence factors in global and regions.

6. To analyze Pemetrexed Disodium for Injection competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Pemetrexed Disodium for Injection market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Pemetrexed Disodium for Injection and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Pemetrexed Disodium for Injection.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Pemetrexed Disodium for Injection market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Pemetrexed Disodium for Injection industry.

Chapter 3: Detailed analysis of Pemetrexed Disodium for Injection manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Pemetrexed Disodium for Injection in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Pemetrexed Disodium for Injection in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Pemetrexed Disodium for Injection Industry Trends Table 2. Pemetrexed Disodium for Injection Industry Drivers Table 3. Pemetrexed Disodium for Injection Industry Opportunities and Challenges Table 4. Pemetrexed Disodium for Injection Industry Restraints Table 5. Global Pemetrexed Disodium for Injection Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Pemetrexed Disodium for Injection Revenue Share by Company (2021-2026) Table 7. Global Pemetrexed Disodium for Injection Sales Volume by Company (k units) & (2021-2026) Table 8. Global Pemetrexed Disodium for Injection Sales Volume Share by Company (2021-2026) Table 9. Global Pemetrexed Disodium for Injection Average Price (US$/unit) of Company (2021-2026) Table 10. Global Pemetrexed Disodium for Injection Company Ranking, (2024-2026) & (USD Million) Table 11. Global Pemetrexed Disodium for Injection Key Company Manufacturing Base & Headquarters Table 12. Global Pemetrexed Disodium for Injection Company, Product Type & Application Table 13. Global Pemetrexed Disodium for Injection Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Pemetrexed Disodium for Injection by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of 500mg/Pcs Table 18. Significant Companies of 100mg/Pcs Table 19. Global Pemetrexed Disodium for Injection Sales Volume by Type 2021 VS 2025 VS 2032 (k units) Table 20. Global Pemetrexed Disodium for Injection Sales Volume by Type (2021-2026) & (k units) Table 21. Global Pemetrexed Disodium for Injection Sales Volume by Type (2027-2032) & (k units) Table 22. Global Pemetrexed Disodium for Injection Sales Volume Share by Type (2021-2026) Table 23. Global Pemetrexed Disodium for Injection Sales Volume Share by Type (2027-2032) Table 24. Global Pemetrexed Disodium for Injection Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 25. Global Pemetrexed Disodium for Injection Sales Value by Type (2021-2026) & (US$ Million) Table 26. Global Pemetrexed Disodium for Injection Sales Value by Type (2027-2032) & (US$ Million) Table 27. Global Pemetrexed Disodium for Injection Sales Value Share by Type (2021-2026) Table 28. Global Pemetrexed Disodium for Injection Sales Value Share by Type (2027-2032) Table 29. Significant Companies of Hospitals Table 30. Significant Companies of Clinics Table 31. Significant Companies of Others Table 32. Global Pemetrexed Disodium for Injection Sales Volume by Application 2021 VS 2025 VS 2032 (k units) Table 33. Global Pemetrexed Disodium for Injection Sales Volume by Application (2021-2026) & (k units) Table 34. Global Pemetrexed Disodium for Injection Sales Volume by Application (2027-2032) & (k units) Table 35. Global Pemetrexed Disodium for Injection Sales Volume Share by Application (2021-2026) Table 36. Global Pemetrexed Disodium for Injection Sales Volume Share by Application (2027-2032) Table 37. Global Pemetrexed Disodium for Injection Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 38. Global Pemetrexed Disodium for Injection Sales Value by Application (2021-2026) & (US$ Million) Table 39. Global Pemetrexed Disodium for Injection Sales Value by Application (2027-2032) & (US$ Million) Table 40. Global Pemetrexed Disodium for Injection Sales Value Share by Application (2021-2026) Table 41. Global Pemetrexed Disodium for Injection Sales Value Share by Application (2027-2032) Table 42. Global Pemetrexed Disodium for Injection Sales by Region: 2021 VS 2025 VS 2032 (k units) Table 43. Global Pemetrexed Disodium for Injection Sales by Region (2021-2026) & (k units) Table 44. Global Pemetrexed Disodium for Injection Sales Market Share by Region (2021-2026) Table 45. Global Pemetrexed Disodium for Injection Sales by Region (2027-2032) & (k units) Table 46. Global Pemetrexed Disodium for Injection Sales Market Share by Region (2027-2032) Table 47. Global Pemetrexed Disodium for Injection Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 48. Global Pemetrexed Disodium for Injection Sales Value by Region (2021-2026) & (US$ Million) Table 49. Global Pemetrexed Disodium for Injection Sales Value Share by Region (2021-2026) Table 50. Global Pemetrexed Disodium for Injection Sales Value by Region (2027-2032) & (US$ Million) Table 51. Global Pemetrexed Disodium for Injection Sales Value Share by Region (2027-2032) Table 52. Global Pemetrexed Disodium for Injection Market Average Price (US$/unit) by Region (2021-2026) Table 53. Global Pemetrexed Disodium for Injection Market Average Price (US$/unit) by Region (2027-2032) Table 54. Global Pemetrexed Disodium for Injection Sales by Country: 2021 VS 2025 VS 2032 (k units) Table 55. Global Pemetrexed Disodium for Injection Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 56. Global Pemetrexed Disodium for Injection Sales by Country (2021-2026) & (k units) Table 57. Global Pemetrexed Disodium for Injection Sales Market Share by Country (2021-2026) Table 58. Global Pemetrexed Disodium for Injection Sales by Country (2027-2032) & (k units) Table 59. Global Pemetrexed Disodium for Injection Sales Market Share by Country (2027-2032) Table 60. Global Pemetrexed Disodium for Injection Sales Value by Country (2021-2026) & (US$ Million) Table 61. Global Pemetrexed Disodium for Injection Sales Value Market Share by Country (2021-2026) Table 62. Global Pemetrexed Disodium for Injection Sales Value by Country (2027-2032) & (US$ Million) Table 63. Global Pemetrexed Disodium for Injection Sales Value Market Share by Country (2027-2032) Table 64. Accord Healthcare Company Information Table 65. Accord Healthcare Business Overview Table 66. Accord Healthcare Pemetrexed Disodium for Injection Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 67. Accord Healthcare Pemetrexed Disodium for Injection Product Portfolio Table 68. Accord Healthcare Recent Development Table 69. Amneal Pharmaceuticals Company Information Table 70. Amneal Pharmaceuticals Business Overview Table 71. Amneal Pharmaceuticals Pemetrexed Disodium for Injection Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 72. Amneal Pharmaceuticals Pemetrexed Disodium for Injection Product Portfolio Table 73. Amneal Pharmaceuticals Recent Development Table 74. APOTEX Company Information Table 75. APOTEX Business Overview Table 76. APOTEX Pemetrexed Disodium for Injection Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 77. APOTEX Pemetrexed Disodium for Injection Product Portfolio Table 78. APOTEX Recent Development Table 79. Biocon Company Information Table 80. Biocon Business Overview Table 81. Biocon Pemetrexed Disodium for Injection Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 82. Biocon Pemetrexed Disodium for Injection Product Portfolio Table 83. Biocon Recent Development Table 84. Dr. Reddy's Laboratories Company Information Table 85. Dr. Reddy's Laboratories Business Overview Table 86. Dr. Reddy's Laboratories Pemetrexed Disodium for Injection Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 87. Dr. Reddy's Laboratories Pemetrexed Disodium for Injection Product Portfolio Table 88. Dr. Reddy's Laboratories Recent Development Table 89. Eugia Pharma Company Information Table 90. Eugia Pharma Business Overview Table 91. Eugia Pharma Pemetrexed Disodium for Injection Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 92. Eugia Pharma Pemetrexed Disodium for Injection Product Portfolio Table 93. Eugia Pharma Recent Development Table 94. Nang Kuang Pharmaceutical Company Information Table 95. Nang Kuang Pharmaceutical Business Overview Table 96. Nang Kuang Pharmaceutical Pemetrexed Disodium for Injection Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 97. Nang Kuang Pharmaceutical Pemetrexed Disodium for Injection Product Portfolio Table 98. Nang Kuang Pharmaceutical Recent Development Table 99. Pfizer (Hospira) Company Information Table 100. Pfizer (Hospira) Business Overview Table 101. Pfizer (Hospira) Pemetrexed Disodium for Injection Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 102. Pfizer (Hospira) Pemetrexed Disodium for Injection Product Portfolio Table 103. Pfizer (Hospira) Recent Development Table 104. Waverley Pharma Company Information Table 105. Waverley Pharma Business Overview Table 106. Waverley Pharma Pemetrexed Disodium for Injection Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 107. Waverley Pharma Pemetrexed Disodium for Injection Product Portfolio Table 108. Waverley Pharma Recent Development Table 109. Zydus Lifesciences Company Information Table 110. Zydus Lifesciences Business Overview Table 111. Zydus Lifesciences Pemetrexed Disodium for Injection Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 112. Zydus Lifesciences Pemetrexed Disodium for Injection Product Portfolio Table 113. Zydus Lifesciences Recent Development Table 114. Baxter Company Information Table 115. Baxter Business Overview Table 116. Baxter Pemetrexed Disodium for Injection Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 117. Baxter Pemetrexed Disodium for Injection Product Portfolio Table 118. Baxter Recent Development Table 119. Beijing Xiehe Pharmaceutical Company Information Table 120. Beijing Xiehe Pharmaceutical Business Overview Table 121. Beijing Xiehe Pharmaceutical Pemetrexed Disodium for Injection Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 122. Beijing Xiehe Pharmaceutical Pemetrexed Disodium for Injection Product Portfolio Table 123. Beijing Xiehe Pharmaceutical Recent Development Table 124. Dezhou Deyao Pharmaceutical Company Information Table 125. Dezhou Deyao Pharmaceutical Business Overview Table 126. Dezhou Deyao Pharmaceutical Pemetrexed Disodium for Injection Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 127. Dezhou Deyao Pharmaceutical Pemetrexed Disodium for Injection Product Portfolio Table 128. Dezhou Deyao Pharmaceutical Recent Development Table 129. Fresenius Kabi Company Information Table 130. Fresenius Kabi Business Overview Table 131. Fresenius Kabi Pemetrexed Disodium for Injection Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 132. Fresenius Kabi Pemetrexed Disodium for Injection Product Portfolio Table 133. Fresenius Kabi Recent Development Table 134. Hainan Jinrui Pharmaceutical Company Information Table 135. Hainan Jinrui Pharmaceutical Business Overview Table 136. Hainan Jinrui Pharmaceutical Pemetrexed Disodium for Injection Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 137. Hainan Jinrui Pharmaceutical Pemetrexed Disodium for Injection Product Portfolio Table 138. Hainan Jinrui Pharmaceutical Recent Development Table 139. Kelun Pharmaceutical Company Information Table 140. Kelun Pharmaceutical Business Overview Table 141. Kelun Pharmaceutical Pemetrexed Disodium for Injection Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 142. Kelun Pharmaceutical Pemetrexed Disodium for Injection Product Portfolio Table 143. Kelun Pharmaceutical Recent Development Table 144. Jiangsu Aosaikang Pharmaceutical Company Information Table 145. Jiangsu Aosaikang Pharmaceutical Business Overview Table 146. Jiangsu Aosaikang Pharmaceutical Pemetrexed Disodium for Injection Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 147. Jiangsu Aosaikang Pharmaceutical Pemetrexed Disodium for Injection Product Portfolio Table 148. Jiangsu Aosaikang Pharmaceutical Recent Development Table 149. Qilu Pharmaceutical Company Information Table 150. Qilu Pharmaceutical Business Overview Table 151. Qilu Pharmaceutical Pemetrexed Disodium for Injection Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 152. Qilu Pharmaceutical Pemetrexed Disodium for Injection Product Portfolio Table 153. Qilu Pharmaceutical Recent Development Table 154. Lilly Company Information Table 155. Lilly Business Overview Table 156. Lilly Pemetrexed Disodium for Injection Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 157. Lilly Pemetrexed Disodium for Injection Product Portfolio Table 158. Lilly Recent Development Table 159. Lianyungang Jaripharm Pharmaceutical Company Information Table 160. Lianyungang Jaripharm Pharmaceutical Business Overview Table 161. Lianyungang Jaripharm Pharmaceutical Pemetrexed Disodium for Injection Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 162. Lianyungang Jaripharm Pharmaceutical Pemetrexed Disodium for Injection Product Portfolio Table 163. Lianyungang Jaripharm Pharmaceutical Recent Development Table 164. Nanjing Pharmaceutical Factory Company Information Table 165. Nanjing Pharmaceutical Factory Business Overview Table 166. Nanjing Pharmaceutical Factory Pemetrexed Disodium for Injection Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 167. Nanjing Pharmaceutical Factory Pemetrexed Disodium for Injection Product Portfolio Table 168. Nanjing Pharmaceutical Factory Recent Development Table 169. Jiangsu Hansoh Pharmaceutical Company Information Table 170. Jiangsu Hansoh Pharmaceutical Business Overview Table 171. Jiangsu Hansoh Pharmaceutical Pemetrexed Disodium for Injection Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 172. Jiangsu Hansoh Pharmaceutical Pemetrexed Disodium for Injection Product Portfolio Table 173. Jiangsu Hansoh Pharmaceutical Recent Development Table 174. Sandoz Company Information Table 175. Sandoz Business Overview Table 176. Sandoz Pemetrexed Disodium for Injection Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 177. Sandoz Pemetrexed Disodium for Injection Product Portfolio Table 178. Sandoz Recent Development Table 179. Zhendong Group Company Information Table 180. Zhendong Group Business Overview Table 181. Zhendong Group Pemetrexed Disodium for Injection Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 182. Zhendong Group Pemetrexed Disodium for Injection Product Portfolio Table 183. Zhendong Group Recent Development Table 184. Shanghai Chemo Wanbang Biopharma Company Information Table 185. Shanghai Chemo Wanbang Biopharma Business Overview Table 186. Shanghai Chemo Wanbang Biopharma Pemetrexed Disodium for Injection Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 187. Shanghai Chemo Wanbang Biopharma Pemetrexed Disodium for Injection Product Portfolio Table 188. Shanghai Chemo Wanbang Biopharma Recent Development Table 189. Sichuan Huiyu Pharmaceutical Company Information Table 190. Sichuan Huiyu Pharmaceutical Business Overview Table 191. Sichuan Huiyu Pharmaceutical Pemetrexed Disodium for Injection Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 192. Sichuan Huiyu Pharmaceutical Pemetrexed Disodium for Injection Product Portfolio Table 193. Sichuan Huiyu Pharmaceutical Recent Development Table 194. Suzhou Erye Pharmaceutical Company Information Table 195. Suzhou Erye Pharmaceutical Business Overview Table 196. Suzhou Erye Pharmaceutical Pemetrexed Disodium for Injection Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 197. Suzhou Erye Pharmaceutical Pemetrexed Disodium for Injection Product Portfolio Table 198. Suzhou Erye Pharmaceutical Recent Development Table 199. Suzhou Thery Pharmaceutical Company Information Table 200. Suzhou Thery Pharmaceutical Business Overview Table 201. Suzhou Thery Pharmaceutical Pemetrexed Disodium for Injection Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 202. Suzhou Thery Pharmaceutical Pemetrexed Disodium for Injection Product Portfolio Table 203. Suzhou Thery Pharmaceutical Recent Development Table 204. Jiangsu Simcere Pharmaceutical Company Information Table 205. Jiangsu Simcere Pharmaceutical Business Overview Table 206. Jiangsu Simcere Pharmaceutical Pemetrexed Disodium for Injection Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 207. Jiangsu Simcere Pharmaceutical Pemetrexed Disodium for Injection Product Portfolio Table 208. Jiangsu Simcere Pharmaceutical Recent Development Table 209. Yangtze River Pharmaceutical Group Company Information Table 210. Yangtze River Pharmaceutical Group Business Overview Table 211. Yangtze River Pharmaceutical Group Pemetrexed Disodium for Injection Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 212. Yangtze River Pharmaceutical Group Pemetrexed Disodium for Injection Product Portfolio Table 213. Yangtze River Pharmaceutical Group Recent Development Table 214. Key Raw Materials Table 215. Raw Materials Key Suppliers Table 216. Pemetrexed Disodium for Injection Distributors List Table 217. Pemetrexed Disodium for Injection Customers List Table 218. Research Programs/Design for This Report Table 219. Authors List of This Report Table 220. Secondary Sources Table 221. Primary Sources List of Figures Figure 1. Pemetrexed Disodium for Injection Product Image Figure 2. Global Pemetrexed Disodium for Injection Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Pemetrexed Disodium for Injection Sales Value (2021-2032) & (US$ Million) Figure 4. Global Pemetrexed Disodium for Injection Sales (2021-2032) & (k units) Figure 5. Global Pemetrexed Disodium for Injection Sales Average Price (US$/unit) & (2021-2032) Figure 6. Global Pemetrexed Disodium for Injection Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. 500mg/Pcs Image Figure 10. 100mg/Pcs Image Figure 11. Global Pemetrexed Disodium for Injection Sales Volume by Type (2021 VS 2025 VS 2032) & (k units) Figure 12. Global Pemetrexed Disodium for Injection Sales Volume Share 2021 VS 2025 VS 2032 Figure 13. Global Pemetrexed Disodium for Injection Sales Volume Share by Type (2021-2032) Figure 14. Global Pemetrexed Disodium for Injection Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 15. Global Pemetrexed Disodium for Injection Sales Value Share 2021 VS 2025 VS 2032 Figure 16. Global Pemetrexed Disodium for Injection Sales Value Share by Type (2021-2032) Figure 17. Hospitals Image Figure 18. Clinics Image Figure 19. Others Image Figure 20. Global Pemetrexed Disodium for Injection Sales Volume by Application (2021 VS 2025 VS 2032) & (k units) Figure 21. Global Pemetrexed Disodium for Injection Sales Volume Share 2021 VS 2025 VS 2032 Figure 22. Global Pemetrexed Disodium for Injection Sales Volume Share by Application (2021-2032) Figure 23. Global Pemetrexed Disodium for Injection Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 24. Global Pemetrexed Disodium for Injection Sales Value Share 2021 VS 2025 VS 2032 Figure 25. Global Pemetrexed Disodium for Injection Sales Value Share by Application (2021-2032) Figure 26. Global Pemetrexed Disodium for Injection Sales by Region: 2021 VS 2025 VS 2032 (k units) Figure 27. Global Pemetrexed Disodium for Injection Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 28. Global Pemetrexed Disodium for Injection Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 29. Global Pemetrexed Disodium for Injection Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 30. North America Pemetrexed Disodium for Injection Sales Value (2021-2032) & (US$ Million) Figure 31. North America Pemetrexed Disodium for Injection Sales Value Share by Country (%), 2025 VS 2032 Figure 32. Europe Pemetrexed Disodium for Injection Sales Value (2021-2032) & (US$ Million) Figure 33. Europe Pemetrexed Disodium for Injection Sales Value Share by Country (%), 2025 VS 2032 Figure 34. Asia-Pacific Pemetrexed Disodium for Injection Sales Value (2021-2032) & (US$ Million) Figure 35. Asia-Pacific Pemetrexed Disodium for Injection Sales Value Share by Country (%), 2025 VS 2032 Figure 36. South America Pemetrexed Disodium for Injection Sales Value (2021-2032) & (US$ Million) Figure 37. South America Pemetrexed Disodium for Injection Sales Value Share by Country (%), 2025 VS 2032 Figure 38. Middle East & Africa Pemetrexed Disodium for Injection Sales Value (2021-2032) & (US$ Million) Figure 39. Middle East & Africa Pemetrexed Disodium for Injection Sales Value Share by Country (%), 2025 VS 2032 Figure 40. USA Pemetrexed Disodium for Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 41. USA Pemetrexed Disodium for Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 42. USA Pemetrexed Disodium for Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 43. Canada Pemetrexed Disodium for Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 44. Canada Pemetrexed Disodium for Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 45. Canada Pemetrexed Disodium for Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 46. Mexico Pemetrexed Disodium for Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 47. Mexico Pemetrexed Disodium for Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 48. Mexico Pemetrexed Disodium for Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 49. Germany Pemetrexed Disodium for Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 50. Germany Pemetrexed Disodium for Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 51. Germany Pemetrexed Disodium for Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 52. France Pemetrexed Disodium for Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 53. France Pemetrexed Disodium for Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 54. France Pemetrexed Disodium for Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 55. U.K. Pemetrexed Disodium for Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 56. U.K. Pemetrexed Disodium for Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 57. U.K. Pemetrexed Disodium for Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 58. Italy Pemetrexed Disodium for Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 59. Italy Pemetrexed Disodium for Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 60. Italy Pemetrexed Disodium for Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 61. Spain Pemetrexed Disodium for Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 62. Spain Pemetrexed Disodium for Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 63. Spain Pemetrexed Disodium for Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 64. Russia Pemetrexed Disodium for Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 65. Russia Pemetrexed Disodium for Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 66. Russia Pemetrexed Disodium for Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 67. Netherlands Pemetrexed Disodium for Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 68. Netherlands Pemetrexed Disodium for Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 69. Netherlands Pemetrexed Disodium for Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 70. Nordic Countries Pemetrexed Disodium for Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 71. Nordic Countries Pemetrexed Disodium for Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 72. Nordic Countries Pemetrexed Disodium for Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 73. China Pemetrexed Disodium for Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 74. China Pemetrexed Disodium for Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 75. China Pemetrexed Disodium for Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 76. Japan Pemetrexed Disodium for Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 77. Japan Pemetrexed Disodium for Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 78. Japan Pemetrexed Disodium for Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 79. South Korea Pemetrexed Disodium for Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 80. South Korea Pemetrexed Disodium for Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 81. South Korea Pemetrexed Disodium for Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 82. India Pemetrexed Disodium for Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 83. India Pemetrexed Disodium for Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 84. India Pemetrexed Disodium for Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 85. Australia Pemetrexed Disodium for Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 86. Australia Pemetrexed Disodium for Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 87. Australia Pemetrexed Disodium for Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 88. Southeast Asia Pemetrexed Disodium for Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 89. Southeast Asia Pemetrexed Disodium for Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 90. Southeast Asia Pemetrexed Disodium for Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 91. Brazil Pemetrexed Disodium for Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 92. Brazil Pemetrexed Disodium for Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 93. Brazil Pemetrexed Disodium for Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 94. Argentina Pemetrexed Disodium for Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 95. Argentina Pemetrexed Disodium for Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 96. Argentina Pemetrexed Disodium for Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 97. Chile Pemetrexed Disodium for Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 98. Chile Pemetrexed Disodium for Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 99. Chile Pemetrexed Disodium for Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 100. Colombia Pemetrexed Disodium for Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 101. Colombia Pemetrexed Disodium for Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 102. Colombia Pemetrexed Disodium for Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 103. Peru Pemetrexed Disodium for Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 104. Peru Pemetrexed Disodium for Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 105. Peru Pemetrexed Disodium for Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 106. Saudi Arabia Pemetrexed Disodium for Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 107. Saudi Arabia Pemetrexed Disodium for Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 108. Saudi Arabia Pemetrexed Disodium for Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 109. Israel Pemetrexed Disodium for Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 110. Israel Arabia Pemetrexed Disodium for Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 111. Israel Arabia Pemetrexed Disodium for Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 112. UAE Pemetrexed Disodium for Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 113. UAE Pemetrexed Disodium for Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 114. UAE Pemetrexed Disodium for Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 115. Turkey Pemetrexed Disodium for Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 116. Turkey Pemetrexed Disodium for Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 117. Turkey Pemetrexed Disodium for Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 118. Iran Pemetrexed Disodium for Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 119. Iran Pemetrexed Disodium for Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 120. Iran Pemetrexed Disodium for Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 121. Egypt Pemetrexed Disodium for Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 122. Egypt Pemetrexed Disodium for Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 123. Egypt Pemetrexed Disodium for Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 124. Pemetrexed Disodium for Injection Value Chain Figure 125. Manufacturing Cost Structure Figure 126. Pemetrexed Disodium for Injection Sales Mode & Process Figure 127. Direct Comparison with Distribution Share Figure 128. Distributors Profiles Figure 129. Years Considered Figure 130. Research Process Figure 131. Key Executives Interviewed

Scope & coverage.

Types
  • 500mg/Pcs
  • 100mg/Pcs
Applications
  • Hospitals
  • Clinics
  • Others
Companies covered
  • Accord Healthcare
  • Amneal Pharmaceuticals
  • APOTEX
  • Biocon
  • Dr. Reddy's Laboratories
  • Eugia Pharma
  • Nang Kuang Pharmaceutical
  • Pfizer (Hospira)
  • Waverley Pharma
  • Zydus Lifesciences
  • Baxter
  • Beijing Xiehe Pharmaceutical
  • Dezhou Deyao Pharmaceutical
  • Fresenius Kabi
  • Hainan Jinrui Pharmaceutical
  • Kelun Pharmaceutical
  • Jiangsu Aosaikang Pharmaceutical
  • Qilu Pharmaceutical
  • Lilly
  • Lianyungang Jaripharm Pharmaceutical
  • Nanjing Pharmaceutical Factory
  • Jiangsu Hansoh Pharmaceutical
  • Sandoz
  • Zhendong Group
  • Shanghai Chemo Wanbang Biopharma
  • Sichuan Huiyu Pharmaceutical
  • Suzhou Erye Pharmaceutical
  • Suzhou Thery Pharmaceutical
  • Jiangsu Simcere Pharmaceutical
  • Yangtze River Pharmaceutical Group

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Pemetrexed Disodium for Injection Sales Value (2021-2032)
  4. 1.2.2 Global Pemetrexed Disodium for Injection Sales Volume (2021-2032)
  5. 1.2.3 Global Pemetrexed Disodium for Injection Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Pemetrexed Disodium for Injection Market Dynamics
  1. 2.1 Pemetrexed Disodium for Injection Industry Trends
  2. 2.2 Pemetrexed Disodium for Injection Industry Drivers
  3. 2.3 Pemetrexed Disodium for Injection Industry Opportunities and Challenges
  4. 2.4 Pemetrexed Disodium for Injection Industry Restraints
3 Pemetrexed Disodium for Injection Market by Company
  1. 3.1 Global Pemetrexed Disodium for Injection Company Revenue Ranking in 2025
  2. 3.2 Global Pemetrexed Disodium for Injection Revenue by Company (2021-2026)
  3. 3.3 Global Pemetrexed Disodium for Injection Sales Volume by Company (2021-2026)
  4. 3.4 Global Pemetrexed Disodium for Injection Average Price by Company (2021-2026)
  5. 3.5 Global Pemetrexed Disodium for Injection Company Ranking (2024-2026)
  6. 3.6 Global Pemetrexed Disodium for Injection Company Manufacturing Base and Headquarters
  7. 3.7 Global Pemetrexed Disodium for Injection Company Product Type and Application
  8. 3.8 Global Pemetrexed Disodium for Injection Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Pemetrexed Disodium for Injection Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Pemetrexed Disodium for Injection Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Pemetrexed Disodium for Injection Market by Type
  1. 4.1 Pemetrexed Disodium for Injection Type Introduction
  2. 4.1.1 500mg/Pcs
  3. 4.1.2 100mg/Pcs
  4. 4.2 Global Pemetrexed Disodium for Injection Sales Volume by Type
  5. 4.2.1 Global Pemetrexed Disodium for Injection Sales Volume by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Pemetrexed Disodium for Injection Sales Volume by Type (2021-2032)
  7. 4.2.3 Global Pemetrexed Disodium for Injection Sales Volume Share by Type (2021-2032)
  8. 4.3 Global Pemetrexed Disodium for Injection Sales Value by Type
  9. 4.3.1 Global Pemetrexed Disodium for Injection Sales Value by Type (2021 VS 2025 VS 2032)
  10. 4.3.2 Global Pemetrexed Disodium for Injection Sales Value by Type (2021-2032)
  11. 4.3.3 Global Pemetrexed Disodium for Injection Sales Value Share by Type (2021-2032)
5 Pemetrexed Disodium for Injection Market by Application
  1. 5.1 Pemetrexed Disodium for Injection Application Introduction
  2. 5.1.1 Hospitals
  3. 5.1.2 Clinics
  4. 5.1.3 Others
  5. 5.2 Global Pemetrexed Disodium for Injection Sales Volume by Application
  6. 5.2.1 Global Pemetrexed Disodium for Injection Sales Volume by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Pemetrexed Disodium for Injection Sales Volume by Application (2021-2032)
  8. 5.2.3 Global Pemetrexed Disodium for Injection Sales Volume Share by Application (2021-2032)
  9. 5.3 Global Pemetrexed Disodium for Injection Sales Value by Application
  10. 5.3.1 Global Pemetrexed Disodium for Injection Sales Value by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global Pemetrexed Disodium for Injection Sales Value by Application (2021-2032)
  12. 5.3.3 Global Pemetrexed Disodium for Injection Sales Value Share by Application (2021-2032)
6 Pemetrexed Disodium for Injection Regional Sales and Value Analysis
  1. 6.1 Global Pemetrexed Disodium for Injection Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Pemetrexed Disodium for Injection Sales by Region (2021-2032)
  3. 6.2.1 Global Pemetrexed Disodium for Injection Sales by Region: 2021-2026
  4. 6.2.2 Global Pemetrexed Disodium for Injection Sales by Region (2027-2032)
  5. 6.3 Global Pemetrexed Disodium for Injection Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Pemetrexed Disodium for Injection Sales Value by Region (2021-2032)
  7. 6.4.1 Global Pemetrexed Disodium for Injection Sales Value by Region: 2021-2026
  8. 6.4.2 Global Pemetrexed Disodium for Injection Sales Value by Region (2027-2032)
  9. 6.5 Global Pemetrexed Disodium for Injection Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Pemetrexed Disodium for Injection Sales Value (2021-2032)
  12. 6.6.2 North America Pemetrexed Disodium for Injection Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Pemetrexed Disodium for Injection Sales Value (2021-2032)
  15. 6.7.2 Europe Pemetrexed Disodium for Injection Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Pemetrexed Disodium for Injection Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Pemetrexed Disodium for Injection Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Pemetrexed Disodium for Injection Sales Value (2021-2032)
  21. 6.9.2 South America Pemetrexed Disodium for Injection Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Pemetrexed Disodium for Injection Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Pemetrexed Disodium for Injection Sales Value Share by Country, 2025 VS 2032
7 Pemetrexed Disodium for Injection Country-level Sales and Value Analysis
  1. 7.1 Global Pemetrexed Disodium for Injection Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Pemetrexed Disodium for Injection Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Pemetrexed Disodium for Injection Sales by Country (2021-2032)
  4. 7.3.1 Global Pemetrexed Disodium for Injection Sales by Country (2021-2026)
  5. 7.3.2 Global Pemetrexed Disodium for Injection Sales by Country (2027-2032)
  6. 7.4 Global Pemetrexed Disodium for Injection Sales Value by Country (2021-2032)
  7. 7.4.1 Global Pemetrexed Disodium for Injection Sales Value by Country (2021-2026)
  8. 7.4.2 Global Pemetrexed Disodium for Injection Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Pemetrexed Disodium for Injection Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Pemetrexed Disodium for Injection Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Pemetrexed Disodium for Injection Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Pemetrexed Disodium for Injection Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Pemetrexed Disodium for Injection Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Pemetrexed Disodium for Injection Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Pemetrexed Disodium for Injection Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Pemetrexed Disodium for Injection Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Pemetrexed Disodium for Injection Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Pemetrexed Disodium for Injection Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Pemetrexed Disodium for Injection Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Pemetrexed Disodium for Injection Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Pemetrexed Disodium for Injection Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Pemetrexed Disodium for Injection Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Pemetrexed Disodium for Injection Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Pemetrexed Disodium for Injection Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Pemetrexed Disodium for Injection Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Pemetrexed Disodium for Injection Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Pemetrexed Disodium for Injection Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Pemetrexed Disodium for Injection Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Pemetrexed Disodium for Injection Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Pemetrexed Disodium for Injection Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Pemetrexed Disodium for Injection Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Pemetrexed Disodium for Injection Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Pemetrexed Disodium for Injection Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Pemetrexed Disodium for Injection Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Pemetrexed Disodium for Injection Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Pemetrexed Disodium for Injection Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Pemetrexed Disodium for Injection Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Pemetrexed Disodium for Injection Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Pemetrexed Disodium for Injection Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Pemetrexed Disodium for Injection Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Pemetrexed Disodium for Injection Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Pemetrexed Disodium for Injection Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Pemetrexed Disodium for Injection Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Pemetrexed Disodium for Injection Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Pemetrexed Disodium for Injection Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Pemetrexed Disodium for Injection Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Pemetrexed Disodium for Injection Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Pemetrexed Disodium for Injection Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Pemetrexed Disodium for Injection Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Pemetrexed Disodium for Injection Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Pemetrexed Disodium for Injection Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Pemetrexed Disodium for Injection Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Pemetrexed Disodium for Injection Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Pemetrexed Disodium for Injection Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Pemetrexed Disodium for Injection Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Pemetrexed Disodium for Injection Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Pemetrexed Disodium for Injection Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Pemetrexed Disodium for Injection Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Pemetrexed Disodium for Injection Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Pemetrexed Disodium for Injection Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Pemetrexed Disodium for Injection Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Pemetrexed Disodium for Injection Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Pemetrexed Disodium for Injection Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Pemetrexed Disodium for Injection Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Pemetrexed Disodium for Injection Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Pemetrexed Disodium for Injection Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Pemetrexed Disodium for Injection Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Pemetrexed Disodium for Injection Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Pemetrexed Disodium for Injection Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Pemetrexed Disodium for Injection Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Pemetrexed Disodium for Injection Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Pemetrexed Disodium for Injection Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Pemetrexed Disodium for Injection Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Pemetrexed Disodium for Injection Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Pemetrexed Disodium for Injection Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Pemetrexed Disodium for Injection Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Pemetrexed Disodium for Injection Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Pemetrexed Disodium for Injection Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Pemetrexed Disodium for Injection Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Pemetrexed Disodium for Injection Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Pemetrexed Disodium for Injection Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Pemetrexed Disodium for Injection Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Pemetrexed Disodium for Injection Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Pemetrexed Disodium for Injection Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Pemetrexed Disodium for Injection Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Pemetrexed Disodium for Injection Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Pemetrexed Disodium for Injection Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Pemetrexed Disodium for Injection Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Pemetrexed Disodium for Injection Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Pemetrexed Disodium for Injection Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Pemetrexed Disodium for Injection Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Pemetrexed Disodium for Injection Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Accord Healthcare
  2. 8.1.1 Accord Healthcare Company Information
  3. 8.1.2 Accord Healthcare Business Overview
  4. 8.1.3 Accord Healthcare Pemetrexed Disodium for Injection Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 Accord Healthcare Pemetrexed Disodium for Injection Product Portfolio
  6. 8.1.5 Accord Healthcare Recent Developments
  7. 8.2 Amneal Pharmaceuticals
  8. 8.2.1 Amneal Pharmaceuticals Company Information
  9. 8.2.2 Amneal Pharmaceuticals Business Overview
  10. 8.2.3 Amneal Pharmaceuticals Pemetrexed Disodium for Injection Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 Amneal Pharmaceuticals Pemetrexed Disodium for Injection Product Portfolio
  12. 8.2.5 Amneal Pharmaceuticals Recent Developments
  13. 8.3 APOTEX
  14. 8.3.1 APOTEX Company Information
  15. 8.3.2 APOTEX Business Overview
  16. 8.3.3 APOTEX Pemetrexed Disodium for Injection Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 APOTEX Pemetrexed Disodium for Injection Product Portfolio
  18. 8.3.5 APOTEX Recent Developments
  19. 8.4 Biocon
  20. 8.4.1 Biocon Company Information
  21. 8.4.2 Biocon Business Overview
  22. 8.4.3 Biocon Pemetrexed Disodium for Injection Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 Biocon Pemetrexed Disodium for Injection Product Portfolio
  24. 8.4.5 Biocon Recent Developments
  25. 8.5 Dr. Reddy's Laboratories
  26. 8.5.1 Dr. Reddy's Laboratories Company Information
  27. 8.5.2 Dr. Reddy's Laboratories Business Overview
  28. 8.5.3 Dr. Reddy's Laboratories Pemetrexed Disodium for Injection Sales, Value and Gross Margin (2021-2026)
  29. 8.5.4 Dr. Reddy's Laboratories Pemetrexed Disodium for Injection Product Portfolio
  30. 8.5.5 Dr. Reddy's Laboratories Recent Developments
  31. 8.6 Eugia Pharma
  32. 8.6.1 Eugia Pharma Company Information
  33. 8.6.2 Eugia Pharma Business Overview
  34. 8.6.3 Eugia Pharma Pemetrexed Disodium for Injection Sales, Value and Gross Margin (2021-2026)
  35. 8.6.4 Eugia Pharma Pemetrexed Disodium for Injection Product Portfolio
  36. 8.6.5 Eugia Pharma Recent Developments
  37. 8.7 Nang Kuang Pharmaceutical
  38. 8.7.1 Nang Kuang Pharmaceutical Company Information
  39. 8.7.2 Nang Kuang Pharmaceutical Business Overview
  40. 8.7.3 Nang Kuang Pharmaceutical Pemetrexed Disodium for Injection Sales, Value and Gross Margin (2021-2026)
  41. 8.7.4 Nang Kuang Pharmaceutical Pemetrexed Disodium for Injection Product Portfolio
  42. 8.7.5 Nang Kuang Pharmaceutical Recent Developments
  43. 8.8 Pfizer (Hospira)
  44. 8.8.1 Pfizer (Hospira) Company Information
  45. 8.8.2 Pfizer (Hospira) Business Overview
  46. 8.8.3 Pfizer (Hospira) Pemetrexed Disodium for Injection Sales, Value and Gross Margin (2021-2026)
  47. 8.8.4 Pfizer (Hospira) Pemetrexed Disodium for Injection Product Portfolio
  48. 8.8.5 Pfizer (Hospira) Recent Developments
  49. 8.9 Waverley Pharma
  50. 8.9.1 Waverley Pharma Company Information
  51. 8.9.2 Waverley Pharma Business Overview
  52. 8.9.3 Waverley Pharma Pemetrexed Disodium for Injection Sales, Value and Gross Margin (2021-2026)
  53. 8.9.4 Waverley Pharma Pemetrexed Disodium for Injection Product Portfolio
  54. 8.9.5 Waverley Pharma Recent Developments
  55. 8.10 Zydus Lifesciences
  56. 8.10.1 Zydus Lifesciences Company Information
  57. 8.10.2 Zydus Lifesciences Business Overview
  58. 8.10.3 Zydus Lifesciences Pemetrexed Disodium for Injection Sales, Value and Gross Margin (2021-2026)
  59. 8.10.4 Zydus Lifesciences Pemetrexed Disodium for Injection Product Portfolio
  60. 8.10.5 Zydus Lifesciences Recent Developments
  61. 8.11 Baxter
  62. 8.11.1 Baxter Company Information
  63. 8.11.2 Baxter Business Overview
  64. 8.11.3 Baxter Pemetrexed Disodium for Injection Sales, Value and Gross Margin (2021-2026)
  65. 8.11.4 Baxter Pemetrexed Disodium for Injection Product Portfolio
  66. 8.11.5 Baxter Recent Developments
  67. 8.12 Beijing Xiehe Pharmaceutical
  68. 8.12.1 Beijing Xiehe Pharmaceutical Company Information
  69. 8.12.2 Beijing Xiehe Pharmaceutical Business Overview
  70. 8.12.3 Beijing Xiehe Pharmaceutical Pemetrexed Disodium for Injection Sales, Value and Gross Margin (2021-2026)
  71. 8.12.4 Beijing Xiehe Pharmaceutical Pemetrexed Disodium for Injection Product Portfolio
  72. 8.12.5 Beijing Xiehe Pharmaceutical Recent Developments
  73. 8.13 Dezhou Deyao Pharmaceutical
  74. 8.13.1 Dezhou Deyao Pharmaceutical Company Information
  75. 8.13.2 Dezhou Deyao Pharmaceutical Business Overview
  76. 8.13.3 Dezhou Deyao Pharmaceutical Pemetrexed Disodium for Injection Sales, Value and Gross Margin (2021-2026)
  77. 8.13.4 Dezhou Deyao Pharmaceutical Pemetrexed Disodium for Injection Product Portfolio
  78. 8.13.5 Dezhou Deyao Pharmaceutical Recent Developments
  79. 8.14 Fresenius Kabi
  80. 8.14.1 Fresenius Kabi Company Information
  81. 8.14.2 Fresenius Kabi Business Overview
  82. 8.14.3 Fresenius Kabi Pemetrexed Disodium for Injection Sales, Value and Gross Margin (2021-2026)
  83. 8.14.4 Fresenius Kabi Pemetrexed Disodium for Injection Product Portfolio
  84. 8.14.5 Fresenius Kabi Recent Developments
  85. 8.15 Hainan Jinrui Pharmaceutical
  86. 8.15.1 Hainan Jinrui Pharmaceutical Company Information
  87. 8.15.2 Hainan Jinrui Pharmaceutical Business Overview
  88. 8.15.3 Hainan Jinrui Pharmaceutical Pemetrexed Disodium for Injection Sales, Value and Gross Margin (2021-2026)
  89. 8.15.4 Hainan Jinrui Pharmaceutical Pemetrexed Disodium for Injection Product Portfolio
  90. 8.15.5 Hainan Jinrui Pharmaceutical Recent Developments
  91. 8.16 Kelun Pharmaceutical
  92. 8.16.1 Kelun Pharmaceutical Company Information
  93. 8.16.2 Kelun Pharmaceutical Business Overview
  94. 8.16.3 Kelun Pharmaceutical Pemetrexed Disodium for Injection Sales, Value and Gross Margin (2021-2026)
  95. 8.16.4 Kelun Pharmaceutical Pemetrexed Disodium for Injection Product Portfolio
  96. 8.16.5 Kelun Pharmaceutical Recent Developments
  97. 8.17 Jiangsu Aosaikang Pharmaceutical
  98. 8.17.1 Jiangsu Aosaikang Pharmaceutical Company Information
  99. 8.17.2 Jiangsu Aosaikang Pharmaceutical Business Overview
  100. 8.17.3 Jiangsu Aosaikang Pharmaceutical Pemetrexed Disodium for Injection Sales, Value and Gross Margin (2021-2026)
  101. 8.17.4 Jiangsu Aosaikang Pharmaceutical Pemetrexed Disodium for Injection Product Portfolio
  102. 8.17.5 Jiangsu Aosaikang Pharmaceutical Recent Developments
  103. 8.18 Qilu Pharmaceutical
  104. 8.18.1 Qilu Pharmaceutical Company Information
  105. 8.18.2 Qilu Pharmaceutical Business Overview
  106. 8.18.3 Qilu Pharmaceutical Pemetrexed Disodium for Injection Sales, Value and Gross Margin (2021-2026)
  107. 8.18.4 Qilu Pharmaceutical Pemetrexed Disodium for Injection Product Portfolio
  108. 8.18.5 Qilu Pharmaceutical Recent Developments
  109. 8.19 Lilly
  110. 8.19.1 Lilly Company Information
  111. 8.19.2 Lilly Business Overview
  112. 8.19.3 Lilly Pemetrexed Disodium for Injection Sales, Value and Gross Margin (2021-2026)
  113. 8.19.4 Lilly Pemetrexed Disodium for Injection Product Portfolio
  114. 8.19.5 Lilly Recent Developments
  115. 8.20 Lianyungang Jaripharm Pharmaceutical
  116. 8.20.1 Lianyungang Jaripharm Pharmaceutical Company Information
  117. 8.20.2 Lianyungang Jaripharm Pharmaceutical Business Overview
  118. 8.20.3 Lianyungang Jaripharm Pharmaceutical Pemetrexed Disodium for Injection Sales, Value and Gross Margin (2021-2026)
  119. 8.20.4 Lianyungang Jaripharm Pharmaceutical Pemetrexed Disodium for Injection Product Portfolio
  120. 8.20.5 Lianyungang Jaripharm Pharmaceutical Recent Developments
  121. 8.21 Nanjing Pharmaceutical Factory
  122. 8.21.1 Nanjing Pharmaceutical Factory Company Information
  123. 8.21.2 Nanjing Pharmaceutical Factory Business Overview
  124. 8.21.3 Nanjing Pharmaceutical Factory Pemetrexed Disodium for Injection Sales, Value and Gross Margin (2021-2026)
  125. 8.21.4 Nanjing Pharmaceutical Factory Pemetrexed Disodium for Injection Product Portfolio
  126. 8.21.5 Nanjing Pharmaceutical Factory Recent Developments
  127. 8.22 Jiangsu Hansoh Pharmaceutical
  128. 8.22.1 Jiangsu Hansoh Pharmaceutical Company Information
  129. 8.22.2 Jiangsu Hansoh Pharmaceutical Business Overview
  130. 8.22.3 Jiangsu Hansoh Pharmaceutical Pemetrexed Disodium for Injection Sales, Value and Gross Margin (2021-2026)
  131. 8.22.4 Jiangsu Hansoh Pharmaceutical Pemetrexed Disodium for Injection Product Portfolio
  132. 8.22.5 Jiangsu Hansoh Pharmaceutical Recent Developments
  133. 8.23 Sandoz
  134. 8.23.1 Sandoz Company Information
  135. 8.23.2 Sandoz Business Overview
  136. 8.23.3 Sandoz Pemetrexed Disodium for Injection Sales, Value and Gross Margin (2021-2026)
  137. 8.23.4 Sandoz Pemetrexed Disodium for Injection Product Portfolio
  138. 8.23.5 Sandoz Recent Developments
  139. 8.24 Zhendong Group
  140. 8.24.1 Zhendong Group Company Information
  141. 8.24.2 Zhendong Group Business Overview
  142. 8.24.3 Zhendong Group Pemetrexed Disodium for Injection Sales, Value and Gross Margin (2021-2026)
  143. 8.24.4 Zhendong Group Pemetrexed Disodium for Injection Product Portfolio
  144. 8.24.5 Zhendong Group Recent Developments
  145. 8.25 Shanghai Chemo Wanbang Biopharma
  146. 8.25.1 Shanghai Chemo Wanbang Biopharma Company Information
  147. 8.25.2 Shanghai Chemo Wanbang Biopharma Business Overview
  148. 8.25.3 Shanghai Chemo Wanbang Biopharma Pemetrexed Disodium for Injection Sales, Value and Gross Margin (2021-2026)
  149. 8.25.4 Shanghai Chemo Wanbang Biopharma Pemetrexed Disodium for Injection Product Portfolio
  150. 8.25.5 Shanghai Chemo Wanbang Biopharma Recent Developments
  151. 8.26 Sichuan Huiyu Pharmaceutical
  152. 8.26.1 Sichuan Huiyu Pharmaceutical Company Information
  153. 8.26.2 Sichuan Huiyu Pharmaceutical Business Overview
  154. 8.26.3 Sichuan Huiyu Pharmaceutical Pemetrexed Disodium for Injection Sales, Value and Gross Margin (2021-2026)
  155. 8.26.4 Sichuan Huiyu Pharmaceutical Pemetrexed Disodium for Injection Product Portfolio
  156. 8.26.5 Sichuan Huiyu Pharmaceutical Recent Developments
  157. 8.27 Suzhou Erye Pharmaceutical
  158. 8.27.1 Suzhou Erye Pharmaceutical Company Information
  159. 8.27.2 Suzhou Erye Pharmaceutical Business Overview
  160. 8.27.3 Suzhou Erye Pharmaceutical Pemetrexed Disodium for Injection Sales, Value and Gross Margin (2021-2026)
  161. 8.27.4 Suzhou Erye Pharmaceutical Pemetrexed Disodium for Injection Product Portfolio
  162. 8.27.5 Suzhou Erye Pharmaceutical Recent Developments
  163. 8.28 Suzhou Thery Pharmaceutical
  164. 8.28.1 Suzhou Thery Pharmaceutical Company Information
  165. 8.28.2 Suzhou Thery Pharmaceutical Business Overview
  166. 8.28.3 Suzhou Thery Pharmaceutical Pemetrexed Disodium for Injection Sales, Value and Gross Margin (2021-2026)
  167. 8.28.4 Suzhou Thery Pharmaceutical Pemetrexed Disodium for Injection Product Portfolio
  168. 8.28.5 Suzhou Thery Pharmaceutical Recent Developments
  169. 8.29 Jiangsu Simcere Pharmaceutical
  170. 8.29.1 Jiangsu Simcere Pharmaceutical Company Information
  171. 8.29.2 Jiangsu Simcere Pharmaceutical Business Overview
  172. 8.29.3 Jiangsu Simcere Pharmaceutical Pemetrexed Disodium for Injection Sales, Value and Gross Margin (2021-2026)
  173. 8.29.4 Jiangsu Simcere Pharmaceutical Pemetrexed Disodium for Injection Product Portfolio
  174. 8.29.5 Jiangsu Simcere Pharmaceutical Recent Developments
  175. 8.30 Yangtze River Pharmaceutical Group
  176. 8.30.1 Yangtze River Pharmaceutical Group Company Information
  177. 8.30.2 Yangtze River Pharmaceutical Group Business Overview
  178. 8.30.3 Yangtze River Pharmaceutical Group Pemetrexed Disodium for Injection Sales, Value and Gross Margin (2021-2026)
  179. 8.30.4 Yangtze River Pharmaceutical Group Pemetrexed Disodium for Injection Product Portfolio
  180. 8.30.5 Yangtze River Pharmaceutical Group Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Pemetrexed Disodium for Injection Value Chain Analysis
  2. 9.1.1 Pemetrexed Disodium for Injection Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Pemetrexed Disodium for Injection Sales Mode & Process
  6. 9.2 Pemetrexed Disodium for Injection Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Pemetrexed Disodium for Injection Distributors
  9. 9.2.3 Pemetrexed Disodium for Injection Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst